Table 2 Association of PinX1 expression with clinicopathological characteristics of PCa patients
From: Reduced expression of PinX1 correlates to progressive features in patients with prostate cancer
Characteristics | PinX1 staining | Total | Pearson Chi-square | P valueb | |
|---|---|---|---|---|---|
Negative (%) | Positive (%) | ||||
Age at surgery (years) | |||||
≤67a | 13 (72.2) | 5 (27.8) | 18 | 0.333 | 0.564 |
>67 | 14 (63.6) | 8 (36.4) | 22 | ||
Histology grade | |||||
I | 4 (50.0) | 4 (50.0) | 8 | 3.569 | 0.168 |
II | 11 (61.1) | 7 (38.9) | 18 | ||
III | 12 (85.7) | 2 (14.3) | 14 | ||
Clinical stage | |||||
I | 0 (0.0) | 1 (100.0) | 1 | 10.230 | 0.017 |
II | 6 (46.2) | 7 (53.8) | 13 | ||
III | 3 (50.0) | 3 (50.0) | 6 | ||
IV | 18 (90.0) | 2 (10.0) | 20 | ||
Gleason pattern | |||||
1 | 1 (33.3) | 2 (66.7) | 3 | 4.177 | 0.383 |
2 | 6 (66.7) | 3 (33.3) | 9 | ||
3 | 4 (50.0) | 4 (50.0) | 8 | ||
4 | 9 (81.8) | 2 (18.2) | 11 | ||
5 | 7 (77.8) | 2 (22.2) | 9 | ||
Gleason score | |||||
1-7 | 14 (56.0) | 11 (44.0) | 25 | 4.019 | 0.045 |
8-10 | 13 (86.7) | 2 (13.3) | 15 | ||
pT status | |||||
T1 | 0 (0.0) | 1 (100.0) | 1 | 7.322 | 0.062 |
T2 | 9 (52.9) | 8 (47.1) | 17 | ||
T3 | 11 (73.3) | 4 (26.7) | 15 | ||
T4 | 7 (100.0) | 0 (0.0) | 7 | ||
pN status | |||||
N0 | 9 (45.0) | 11 (55.0) | 20 | 10.852 | 0.004 |
N1 | 17 (94.4) | 1 (5.6) | 18 | ||
N2 | 1 (50.0) | 1 (50.0) | 2 | ||
pM status | |||||
M0 | 10 (47.6) | 11 (52.4) | 21 | 7.965 | 0.005 |
M1 | 17 (89.5) | 2 (10.5) | 19 | ||